Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason B White

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
JCO Precision Oncology|March 14, 2024
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer SubtypesReva K Basho, Li Zhao, Jason B White, et al.
Frontiers in Artificial Intelligence|August 29, 2022
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerEhsan Irajizad, Ranran Wu, Jody Vykoukal, et al.
BMC Cancer|August 15, 2024
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNAJennifer H Chen, Sridevi Addanki, Dhruvajyoti Roy, et al.
Academic Radiology|July 17, 2021
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRosalind P Candelaria, David A Spak, Gaiane M Rauch, et al.
Scientific Reports|October 22, 2020
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancerReid T Powell, Abena Redwood, Xuan Liu, et al.
Breast Cancer Research and Treatment|June 1, 2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trialKamaria L Lee, Clinton Yam, Li Zhao, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Cancer Research|August 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples During Neoadjuvant ChemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Breast Cancer Research and Treatment|April 15, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancerClinton Yam, Elizabeth A Mittendorf, Haven R Garber, et al.
Radiology. Imaging Cancer|July 28, 2023
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast CancerKen-Pin Hwang, Nabil A Elshafeey, Aikaterini Kotrotsou, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
JCO Precision Oncology|March 14, 2024
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer SubtypesReva K Basho, Li Zhao, Jason B White, et al.
Frontiers in Artificial Intelligence|August 29, 2022
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerEhsan Irajizad, Ranran Wu, Jody Vykoukal, et al.
BMC Cancer|August 15, 2024
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNAJennifer H Chen, Sridevi Addanki, Dhruvajyoti Roy, et al.
Academic Radiology|July 17, 2021
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRosalind P Candelaria, David A Spak, Gaiane M Rauch, et al.
Scientific Reports|October 22, 2020
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancerReid T Powell, Abena Redwood, Xuan Liu, et al.
Breast Cancer Research and Treatment|June 1, 2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trialKamaria L Lee, Clinton Yam, Li Zhao, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Cancer Research|August 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples During Neoadjuvant ChemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Breast Cancer Research and Treatment|April 15, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancerClinton Yam, Elizabeth A Mittendorf, Haven R Garber, et al.
Radiology. Imaging Cancer|July 28, 2023
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast CancerKen-Pin Hwang, Nabil A Elshafeey, Aikaterini Kotrotsou, et al.
Pageof 6